April 21, 2017

Helsinki institutions team up abroad for health

Collaborations bring new research opportunities to students and doctors.
Collaborations bring new research opportunities to students and doctors.
Istock.com/poba

The Hospital District of Helsinki and Uusimaa (HUS) and the University of Helsinki are collaborating with Pfizer and GlaxoSmithKline through new partner contracts.

Pfizer and the two Helsinkians have signed a partnership contract that aims to develop medical research in Finland. The co-operation covers fields such as the effectiveness of medical care, developing targeted drugs and genetic research.

Earlier this month, the university and HUS partnered with GlaxoSmithKline in order to collaborate in various fields of medical speciality.

During the past year, HUS and the University of Helsinki have signed various agreements of co-operation with big medical companies. According to Risto Renkonen, dean of the faculty of medicine, this is in attempt to increase the amount of clinical research on campus, improve the both the impact and cost-effectiveness of health care and bring new research opportunities to doctors, researchers and students.

Share: